世界の無針ドラッグデリバリー市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21JY00001)
◆英語タイトル:Global Needle-Free Drug Delivery Market 2021 by Company, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21JY00001
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:95
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、無針ドラッグデリバリーの世界市場を広く調査・分析し、今後の市場展望をまとめております。無針ドラッグデリバリーの種類別市場規模(ジェット、スプリング、レーザー)、用途別市場規模(インスリン投与、予防接種、疼痛管理)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Antares Pharma、Pharmajet、Optinose、Valeritas、Crossject、Injex Pharma、3M Pharmaceuticals、Becton Dickinson (BD)、MedImmune、Mystic Pharmaceuticals、Zogenix
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:ジェット、スプリング、レーザー
・用途別分析2016年-2026年:インスリン投与、予防接種、疼痛管理
・無針ドラッグデリバリーの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・無針ドラッグデリバリーのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・無針ドラッグデリバリーのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・無針ドラッグデリバリーの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・無針ドラッグデリバリーの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Needle-Free Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Needle-Free Drug Delivery size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Needle-Free Drug Delivery market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Needle-Free Drug Delivery market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Jet-based
Spring-based
Laser-based

Market segment by Application, can be divided into
Insulin delivery
Vaccination
Pain management

Market segment by players, this report covers
Antares Pharma
Pharmajet
Optinose
Valeritas
Crossject
Injex Pharma
3M Pharmaceuticals
Becton Dickinson (BD)
MedImmune
Mystic Pharmaceuticals
Zogenix

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Needle-Free Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Needle-Free Drug Delivery, with revenue, gross margin and global market share of Needle-Free Drug Delivery from 2019 to 2021.
Chapter 3, the Needle-Free Drug Delivery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Needle-Free Drug Delivery market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Needle-Free Drug Delivery research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Product Overview and Scope of Needle-Free Drug Delivery
1.2 Classification of Needle-Free Drug Delivery by Type
1.2.1 Overview: Global Needle-Free Drug Delivery Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Needle-Free Drug Delivery Revenue Market Share by Type in 2020
1.2.3 Jet-based
1.2.4 Spring-based
1.2.5 Laser-based
1.3 Global Needle-Free Drug Delivery Market by Application
1.3.1 Overview: Global Needle-Free Drug Delivery Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Insulin delivery
1.3.3 Vaccination
1.3.4 Pain management
1.4 Global Needle-Free Drug Delivery Market Size & Forecast
1.5 Global Needle-Free Drug Delivery Market Size and Forecast by Region
1.5.1 Global Needle-Free Drug Delivery Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Needle-Free Drug Delivery Market Size by Region, (2016-2021)
1.5.3 North America Needle-Free Drug Delivery Market Size and Prospect (2016-2026)
1.5.4 Europe Needle-Free Drug Delivery Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Needle-Free Drug Delivery Market Size and Prospect (2016-2026)
1.5.6 South America Needle-Free Drug Delivery Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Needle-Free Drug Delivery Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Needle-Free Drug Delivery Market Drivers
1.6.2 Needle-Free Drug Delivery Market Restraints
1.6.3 Needle-Free Drug Delivery Trends Analysis
2 Company Profiles
2.1 Antares Pharma
2.1.1 Antares Pharma Details
2.1.2 Antares Pharma Major Business
2.1.3 Antares Pharma Needle-Free Drug Delivery Product and Solutions
2.1.4 Antares Pharma Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Antares Pharma Recent Developments and Future Plans
2.2 Pharmajet
2.2.1 Pharmajet Details
2.2.2 Pharmajet Major Business
2.2.3 Pharmajet Needle-Free Drug Delivery Product and Solutions
2.2.4 Pharmajet Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pharmajet Recent Developments and Future Plans
2.3 Optinose
2.3.1 Optinose Details
2.3.2 Optinose Major Business
2.3.3 Optinose Needle-Free Drug Delivery Product and Solutions
2.3.4 Optinose Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Optinose Recent Developments and Future Plans
2.4 Valeritas
2.4.1 Valeritas Details
2.4.2 Valeritas Major Business
2.4.3 Valeritas Needle-Free Drug Delivery Product and Solutions
2.4.4 Valeritas Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Valeritas Recent Developments and Future Plans
2.5 Crossject
2.5.1 Crossject Details
2.5.2 Crossject Major Business
2.5.3 Crossject Needle-Free Drug Delivery Product and Solutions
2.5.4 Crossject Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Crossject Recent Developments and Future Plans
2.6 Injex Pharma
2.6.1 Injex Pharma Details
2.6.2 Injex Pharma Major Business
2.6.3 Injex Pharma Needle-Free Drug Delivery Product and Solutions
2.6.4 Injex Pharma Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Injex Pharma Recent Developments and Future Plans
2.7 3M Pharmaceuticals
2.7.1 3M Pharmaceuticals Details
2.7.2 3M Pharmaceuticals Major Business
2.7.3 3M Pharmaceuticals Needle-Free Drug Delivery Product and Solutions
2.7.4 3M Pharmaceuticals Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 3M Pharmaceuticals Recent Developments and Future Plans
2.8 Becton Dickinson (BD)
2.8.1 Becton Dickinson (BD) Details
2.8.2 Becton Dickinson (BD) Major Business
2.8.3 Becton Dickinson (BD) Needle-Free Drug Delivery Product and Solutions
2.8.4 Becton Dickinson (BD) Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Becton Dickinson (BD) Recent Developments and Future Plans
2.9 MedImmune
2.9.1 MedImmune Details
2.9.2 MedImmune Major Business
2.9.3 MedImmune Needle-Free Drug Delivery Product and Solutions
2.9.4 MedImmune Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 MedImmune Recent Developments and Future Plans
2.10 Mystic Pharmaceuticals
2.10.1 Mystic Pharmaceuticals Details
2.10.2 Mystic Pharmaceuticals Major Business
2.10.3 Mystic Pharmaceuticals Needle-Free Drug Delivery Product and Solutions
2.10.4 Mystic Pharmaceuticals Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Mystic Pharmaceuticals Recent Developments and Future Plans
2.11 Zogenix
2.11.1 Zogenix Details
2.11.2 Zogenix Major Business
2.11.3 Zogenix Needle-Free Drug Delivery Product and Solutions
2.11.4 Zogenix Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Zogenix Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Needle-Free Drug Delivery Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Needle-Free Drug Delivery Players Market Share
3.2.2 Top 10 Needle-Free Drug Delivery Players Market Share
3.2.3 Market Competition Trend
3.3 Needle-Free Drug Delivery Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Needle-Free Drug Delivery Revenue and Market Share by Type (2016-2021)
4.2 Global Needle-Free Drug Delivery Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Needle-Free Drug Delivery Revenue Market Share by Application (2016-2021)
5.2 Needle-Free Drug Delivery Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Needle-Free Drug Delivery Revenue by Type (2016-2026)
6.2 North America Needle-Free Drug Delivery Revenue by Application (2016-2026)
6.3 North America Needle-Free Drug Delivery Market Size by Country
6.3.1 North America Needle-Free Drug Delivery Revenue by Country (2016-2026)
6.3.2 United States Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
6.3.3 Canada Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
6.3.4 Mexico Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Needle-Free Drug Delivery Revenue by Type (2016-2026)
7.2 Europe Needle-Free Drug Delivery Revenue by Application (2016-2026)
7.3 Europe Needle-Free Drug Delivery Market Size by Country
7.3.1 Europe Needle-Free Drug Delivery Revenue by Country (2016-2026)
7.3.2 Germany Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
7.3.3 France Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
7.3.5 Russia Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
7.3.6 Italy Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Needle-Free Drug Delivery Revenue by Type (2016-2026)
8.2 Asia-Pacific Needle-Free Drug Delivery Revenue by Application (2016-2026)
8.3 Asia-Pacific Needle-Free Drug Delivery Market Size by Region
8.3.1 Asia-Pacific Needle-Free Drug Delivery Revenue by Region (2016-2026)
8.3.2 China Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
8.3.3 Japan Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
8.3.4 South Korea Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
8.3.5 India Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
8.3.7 Australia Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Needle-Free Drug Delivery Revenue by Type (2016-2026)
9.2 South America Needle-Free Drug Delivery Revenue by Application (2016-2026)
9.3 South America Needle-Free Drug Delivery Market Size by Country
9.3.1 South America Needle-Free Drug Delivery Revenue by Country (2016-2026)
9.3.2 Brazil Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
9.3.3 Argentina Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Needle-Free Drug Delivery Revenue by Type (2016-2026)
10.2 Middle East & Africa Needle-Free Drug Delivery Revenue by Application (2016-2026)
10.3 Middle East & Africa Needle-Free Drug Delivery Market Size by Country
10.3.1 Middle East & Africa Needle-Free Drug Delivery Revenue by Country (2016-2026)
10.3.2 Turkey Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
10.3.4 UAE Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

...

【掲載企業】

Antares Pharma、Pharmajet、Optinose、Valeritas、Crossject、Injex Pharma、3M Pharmaceuticals、Becton Dickinson (BD)、MedImmune、Mystic Pharmaceuticals、Zogenix

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の無針ドラッグデリバリー市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Needle-Free Drug Delivery Market 2021 by Company, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。